Experience with Haemate P in von Willebrand's disease in adults.
The virally inactivated pasteurized FVIII concentrate Haemate P contains nearly intact vWF multimers. It is currently the treatment of choice to achieve satisfactory hemostasis for moderate to severe vWD and for patients with variants of vWD that cannot be adequately treated with DDAVP or for whom DDAVP is contraindicated. Therefore, we treated patients with type Ia, type IIa, type IIb and type III vWD with Haemate P. A correction of the hemostatic defect was seen in all patients. The type of bleeding events included 24 gastrointestinal, 18 other mucosal, 5 central nervous system, 15 orthopedic and 4 other. 28 dental surgical procedures, 9 operative deliveries, 5 tonsillectomies, 17 orthopedic and 11 miscellaneous surgeries were performed under the cover of Haemate P.
Center of Internal Medicine, University Hospital, Frankfurt, Germany.
I
I
Scharrer
T
T
Vigh
E
E
Aygören-Pürsün
D000075202:Contraindications; D003894:Deamino Arginine Vasopressin; D005169:Factor VIII / Q000627:therapeutic use*; D006487:Hemostasis; D006801:Humans; D014842:von Willebrand Diseases / Q000188:drug therapy*
D005169:Factor VIII; D003894:Deamino Arginine Vasopressin